8561 - 8570 of 8818 Results
Title
Year
-
OPENTitle: Modeling and prediction of clinical symptom trajectories in Alzheimer’s disease using longitudinal dataJournal Name: PLOS Computational BiologyPublisher: Public Library of Science (PLoS)Vol: 14Issue #: 9Start Page: e1006376End Page: e1006376Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pcbi.1006376Best OA location URL: https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1006376&type=printableCitation Count: 138
- Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 42018OPENTitle: Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4Journal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-018-1337-8Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-018-1337-8Citation Count: 42
-
OPENTitle: The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-018-34490-9Best OA location URL: https://www.nature.com/articles/s41598-018-34490-9.pdfCitation Count: 143
-
OPENTitle: Origins of atrophy in Parkinson linked to early onset and local transcription patternsJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 2Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaa065Best OA location URL: https://academic.oup.com/braincomms/article-pdf/2/2/fcaa065/33715788/fcaa065.pdfCitation Count: 9
-
OPENTitle: Validation of differentially expressed brain‐enriched microRNAs in the plasma of PD patientsJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 7Issue #: 9Start Page: 1594End Page: 1607Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51146Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51146Citation Count: 55
-
OPENTitle: Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 13Issue #: 3Start Page: e0192497End Page: e0192497Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0192497Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0192497&type=printableCitation Count: 25
-
OPENTitle: The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptorJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-018-1100-1Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-018-1100-1Citation Count: 148
- Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation2018OPENTitle: Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylationJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-018-0235-yBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-018-0235-yCitation Count: 106
-
OPENTitle: Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapyJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-018-0245-9Best OA location URL: https://doi.org/10.1186/s13024-018-0245-9Citation Count: 65
-
OPENTitle: The Effect of Obesity on the Availabilities of Dopamine and Serotonin TransportersJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-018-22814-8Best OA location URL: https://www.nature.com/articles/s41598-018-22814-8.pdfCitation Count: 43